Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 34 Leiomyoma 12 Menorrhagia 5 Endometriosis 4 Myofibroma 3 Prostate Adenocarcinoma 2 Pregnancy Complications 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Hemorrhage 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Hormone Treatment-naïve Participants With Prostate Cancer 1

Interventions

Terlipressin 4 Sodium Chloride 4 Vasopressins 3 Uterine Myomectomy 3 Uterine Artery Embolization 3 carbetocin 2 testo 1 relugolix 1 Ultrasonography 1 Tourniquets 1 Saline Solution 1 Radiofrequency Ablation 1 Oxytocin 1 Ofloxacin 1 MoxDuo 1 Misoprostol 1 Magnesium Sulfate 1 Hysteroscopy 1 Ethamsylate 1 Embolization, Therapeutic 1 Doxycycline 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myoma × relugolix × Clear all

NCT06953076 2025-08-17

MySaturn

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Leiomyoma, Myoma, Uterine Hemorrhage, Uterine Neoplasms, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡